Cervarix
Sign in to saveCervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV).
~6 min read
Article
13 sectionsContents
- Medical uses
- Administration
- Limitations of effectiveness
- Adverse effects
- Ingredients
- Biotechnology
- History
- Clinical trials
- Society and culture
- Legal status
- References
- Further reading
- External links
Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV).
Cervarix is designed to prevent infection from HPV types 16 and 18, that cause about 70% of cervical cancer cases. These types also cause most HPV-induced genital and head and neck cancers. Additionally, some cross-reactive protection against virus strains 45 and 31 were shown in clinical trials. Cervarix also contains AS04, a proprietary adjuvant that has been found to boost the immune system response for a longer period of time.
Connections
human papillomavirus infection
Entity
anogenital venereal wart
Entity
University of Queensland
Entity
HPV vaccine
Entity
Europe
Entity
North America
Entity
Louis Pasteur
Entity
Latin America
Entity
vaccine
Entity
immunity
Entity
The New York Times
Entity
Wayback Machine
Entity
Edward Jenner
Entity
vaccination
Entity
digital object identifier
Entity
infection
Entity
histology
Entity
epidemiology
Entity
Reuters
Entity
Jonas Salk
Entity